Pharmacogenomic Biomarkers for Improved Drug Therapy—Recent Progress and Future Developments
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1550-7416
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pharmacogenomic Biomarkers for Improved Drug Therapy—Recent Progress and Future Developments ; volume:20 ; number:1 ; day:27 ; month:11 ; year:2017 ; pages:1-16 ; date:1.2018
The AAPS journal / American Association of Pharmaceutical Scientists ; 20, Heft 1 (27.11.2017), 1-16, 1.2018
- Keyword
-
Arzneimittelentwicklung
Arzneimitteldesign
- Creator
-
Lauschke, Volker M.
- Contributor
-
Milani, Lili
Ingelman-Sundberg, Magnus
SpringerLink (Online service)
- DOI
-
10.1208/s12248-017-0161-x
- URN
-
urn:nbn:de:1111-2018022320961
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lauschke, Volker M.
- Milani, Lili
- Ingelman-Sundberg, Magnus
- SpringerLink (Online service)
Other Objects (12)
Discovering biomarkers of drug efficacy in cancer from pharmacogenomic data
Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis
Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
Comprehensive pharmacogenomic characterization of gastric cancer
Identification of Pharmacogenomic and Functional Biomarkers for Antidepressant Treatment Outcome in Patients-Derived Lymphoblastoid Cell Lines
Drinking water microbiology : progress and recent developments
Progress in developments of dry coal beneficiation
Investigation of community pharmacists’ knowledge and attitudes of pharmacogenomics testing: implication for improved pharmacogenomic testing practice
Reply to Sun: Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection
Status and progress in global lake database developments
Agata detector technology: recent progress and future developments
A Landscape of Pharmacogenomic Interactions in Cancer
Discovering biomarkers of drug efficacy in cancer from pharmacogenomic data
Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis
Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
Comprehensive pharmacogenomic characterization of gastric cancer
Identification of Pharmacogenomic and Functional Biomarkers for Antidepressant Treatment Outcome in Patients-Derived Lymphoblastoid Cell Lines
Drinking water microbiology : progress and recent developments
Progress in developments of dry coal beneficiation
Investigation of community pharmacists’ knowledge and attitudes of pharmacogenomics testing: implication for improved pharmacogenomic testing practice
Reply to Sun: Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection
Status and progress in global lake database developments
Agata detector technology: recent progress and future developments
A Landscape of Pharmacogenomic Interactions in Cancer
Discovering biomarkers of drug efficacy in cancer from pharmacogenomic data
Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis
Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
Comprehensive pharmacogenomic characterization of gastric cancer
Identification of Pharmacogenomic and Functional Biomarkers for Antidepressant Treatment Outcome in Patients-Derived Lymphoblastoid Cell Lines
Drinking water microbiology : progress and recent developments
Progress in developments of dry coal beneficiation
Investigation of community pharmacists’ knowledge and attitudes of pharmacogenomics testing: implication for improved pharmacogenomic testing practice
Reply to Sun: Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection
Status and progress in global lake database developments
Agata detector technology: recent progress and future developments